Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

PRE

Prenetics Global Limited

Jun 14 • 04:00PM ET

5.95

Dollar change -0.05
Percentage change -0.83	%

Healthcare • Diagnostics & Research • Hong Kong • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.85	Insider Own	42.69%	Shs Outstand	10.62M	Perf Week	-2.46%
Market Cap	72.71M	Forward P/E	-	EPS next Y	-0.74	Insider Trans	0.00%	Shs Float	7.00M	Perf Month	-0.34%
Income	-64.82M	PEG	-	EPS next Q	-0.96	Inst Own	11.34%	Short Float	0.64%	Perf Quarter	27.14%
Sales	33.69M	P/S	2.16	EPS this Y	-42.18%	Inst Trans	-15.43%	Short Ratio	0.41	Perf Half Y	42.00%
Book/sh	16.91	P/B	0.35	EPS next Y	79.39%	ROA	-19.70%	Short Interest	0.04M	Perf Year	-54.92%
Cash/sh	5.95	P/C	1.00	EPS next 5Y	-	ROE	-25.15%	52W Range	2.85 - 14.55	Perf YTD	0.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-31.28%	52W High	-59.11%	Beta	-0.14
Dividend TTM	-	Quick Ratio	2.08	Sales past 5Y	-15.03%	Gross Margin	42.48%	52W Low	108.77%	ATR (14)	0.34
Dividend Ex-Date	Feb 17, 2016	Current Ratio	2.16	EPS Y/Y TTM	87.07%	Oper. Margin	-159.69%	RSI (14)	55.38	Volatility	3.63% 4.17%
Employees	324	Debt/Eq	0.01	Sales Y/Y TTM	-81.66%	Profit Margin	-192.41%	Recom	1.00	Target Price	9.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-1160.86%	Payout	-	Rel Volume	0.29	Prev Close	6.00
Sales Surprise	0.00%	EPS Surprise	0.00%	Sales Q/Q	-89.62%	Earnings	Jun 03	Avg Volume	109.70K	Price	5.95
SMA20	0.35%	SMA50	16.84%	SMA200	10.78%	Trades		Volume	31,715	Change	-0.83%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-18-23	Initiated	Cantor Fitzgerald	Overweight	$7

Apr-01-24 01:53PM	PRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:30AM	Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-09-24 09:25AM	Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station (GlobeNewswire)
Nov-20-23 06:00AM	Prenetics Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-01-23 06:00AM	Prenetics Global Limited Announces Reverse Stock Split (GlobeNewswire)
07:10AM	Loading…
Sep-15-23 07:10AM	Prenetics Announces Second Quarter 2023 Financial Results (PR Newswire)
Aug-29-23 12:46AM	A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television (PR Newswire)
Jun-30-23 08:00AM	Prenetics Global signs "transformational" $200mln deal to create cancer screening JV (News Direct) +5.65%
Jun-26-23 09:30AM	Prenetics Announces $200M JV with Prof. Dennis Lo for Multi-Cancer Early Detection Screening (Exec Edge)
Jun-25-23 08:45PM	Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture Insighta for Breakthrough Multi-Cancer Early Detection Screening (GlobeNewswire)
Jun-05-23 07:20AM	Prenetics Announces First Quarter 2023 Financial Results (PR Newswire) +7.97%
Mar-14-23 08:56AM	Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) -6.40%
Mar-02-23 07:00AM	Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology (PR Newswire)
Feb-02-23 04:01PM	Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-19-23 05:00AM	Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA (PR Newswire) -5.52%
10:00AM	Loading…
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference (ACCESSWIRE) -13.56%
Jan-10-23 08:05AM	Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors (PR Newswire) +22.04%
Dec-16-22 06:27AM	Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology (GlobeNewswire) +17.10%
Nov-30-22 09:15AM	Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index (PR Newswire)
Nov-10-22 08:00AM	Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance (GlobeNewswire)
Sep-09-22 11:17AM	Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook (PR Newswire) +11.81%
Aug-12-22 09:34AM	The past year for Prenetics Global (NASDAQ:PRE) investors has not been profitable (Simply Wall St.)
Aug-08-22 04:45AM	Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device (PR Newswire)
Jul-16-22 08:03AM	What Kind Of Investors Own Most Of Prenetics Global Limited (NASDAQ:PRE)? (Simply Wall St.)
Jun-08-22 12:56PM	Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong (PR Newswire)
Jun-06-22 09:55AM	Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker "PRE" (PR Newswire)
May-23-22 12:00PM	Video Highlights Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat (IPO-Edge.com)
08:46AM	New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer (PR Newswire)
May-19-22 12:15PM	Replay Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat (IPO-Edge.com) -26.41%
May-18-22 06:30PM	Prenetics Rings the Opening Bell and Debuts on Nasdaq (GlobeNewswire)
11:00AM	Loading…
May-17-22 11:00AM	Covid Testing The English Premier League and Beyond : Join CEOs of Prenetics, Artisan in Fireside 10AM ET Thurs (IPO-Edge.com)

Prenetics Global Ltd. is a genomics-driven health sciences company, which is revolutionizing prevention, early detection, and treatment of diseases. Its prevention arm, CircleDNA, uses whole exome sequencing to offer the comprehensive consumer DNA test, Insighta. Its $200 million joint venture with scientist Prof. Dennis Lo, underscores its unwavering commitment to save lives through pioneering multi-cancer early detection technologies. The company's ACT Genomics unit is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. The firm's units synergistically enhances its global impact on health and life through science. Prenetics Global was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRE

Prenetics Global Limited

Upgrade your FINVIZ experience